Researchers create bone-implant interaction mouse model to assess tissue response to biomaterials

To understand the molecular mechanisms involved in the interaction of bone with orthopedic implants comprised of novel biomaterials, researchers have made a mouse model in which they can assess early tissue responses to surfaces such as bioactive glass. The ease of genetically modifying this mouse model makes it especially valuable in designing novel biomaterials for use in regenerative medicine, as describe in an article published in Tissue Engineering, Part C Methods, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/). The article is available free on the Tissue Engineering (http://online.liebertpub.com/doi/full/10.1089/ten.tec.2016.0250) website until February 5, 2017.

The article entitled "A Bone-Implant Interaction Mouse Model for Evaluating Molecular Mechanism of Biomaterials/Bone Interaction (http://online.liebertpub.com/doi/full/10.1089/ten.tec.2016.0250)" is coauthored by Wenlong Liu, PhD and colleagues from Shenzen Institutes of Advanced Technology, Chinese Academy of Sciences, The University of Hong Kong, and The Chinese University of Hong Kong, Shenzhen, China. They present results demonstrating the feasibility and reliability of the mouse model using various biomaterials.

"This very accessible and elegant model brings the assessment of bone replacing biomaterial to a new level," says Tissue Engineering, Part C: Methods Co-Editor-in-Chief John A. Jansen, DDS, PhD, Professor Dentistry - Biomaterials, Radboud University Medical Center, Nijmegen, Netherlands.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial finds pomalidomide effective for treating rare bleeding disorder